FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services home page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizontal rule

Table 1 CDER Approval Times for Priority and Standard NMEs and New BLAs

1995 Priority Review resulted in 16 approvals with a median total approval time of 7.9 months.

1995 Standard Review resulted in 67 approvals with a median total approval time of 18.7 months.

1996 Priority Review resulted in 29 approvals with a median total approval time of 7.8 months.

1996 Standard Review resulted in 102 approvals with a median total approval time of 17.8 months.

1997 Priority Review resulted in 20 approvals with a median total approval time of 6.4 months.

1997 Standard Review resulted in 101 approvals with a median total approval time of 15 months.

1998 Priority Review resulted in 25 approvals with a median total approval time of 6.4 months.

1998 Standard Review resulted in 65 approvals with a median total approval time of 12 months.

1999 Priority Review resulted in 28 approvals with a median total approval time of 6.1 months.

1999 Standard Review resulted in 55 approvals with a median total approval time of 13.8 months.

2000 Priority Review resulted in 20 approvals with a median total approval time of 6.0 months.

2000 Standard Review resulted in 78 approvals with a median total approval time of 12 months.

2001 Priority Review resulted in 10 approvals with a median total approval time of 6.0 months.

2001 Standard Review resulted in 56 approvals with a median total approval time of 14 months.

2002 Priority Review resulted in 11 approvals with a median total approval time of 19.1 months.

2002 Standard Review resulted in 67 approvals with a median total approval time of 15.3 months.

2003 Priority Review resulted in 14 approvals with a median total approval time of 7.7 months.

2003 Standard Review resulted in 58 approvals with a median total approval time of 15.4 months.

2004 Priority Review resulted in 29 approvals with a median total approval time of 6.0 months.

2004 Standard Review resulted in 90 approvals with a median total approval time of 12.9 months.

Beginning in 2004, these figures include BLAs for therapeutic biologic products transferred from CBER to CDER effective 10/1/2003.

Return to Table 1

horizontal rule